• pelespirit@sh.itjust.works
    link
    fedilink
    arrow-up
    47
    arrow-down
    1
    ·
    9 days ago

    At least we know who’s buying them. I bet it’s a cheap price.

    The court intervened after the Food and Drug Administration was ordered on May 1 to revive a requirement that doctors prescribe the drug only after an in-person exam. It was the first time access to mifepristone had been significantly curtailed during years of litigation over the the drug, which was first approved in 2000.

    At the request of drug makers, Justice Samuel Alito paused until at least May 11 the restrictive ruling by a lower court while the full court decides what the rules for mifepristone should be as Louisiana challenges expanded access.